Costa Rica: Pharmaceutical products
HS chapter 30 · Chemicals
Pharmaceutical products
Costa Rica pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$105.9 million | 44.6% |
| 3002 Human blood | US$80.6 million | 33.9% |
| 3006 Pharmaceutical goods | US$29.4 million | 12.4% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$12.4 million | 5.2% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$5.8 million | 2.4% |
| 3003 Medicaments | US$3.5 million | 1.5% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$86.3 million | 36.3% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$80.3 million | 33.8% |
| 300610 Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents and absorbable surgical or dental haemostatics | US$24.7 million | 10.4% |
| 300190 Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | US$12.3 million | 5.2% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$7.4 million | 3.1% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$4.5 million | 1.9% |
| 300660 Pharmaceutical goods: chemical contraceptive preparations based on hormones or spermicides | US$4.1 million | 1.7% |
| 300590 Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | US$3.7 million | 1.5% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$3.4 million | 1.5% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$2.8 million | 1.2% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$696.8 million | 65.1% |
| 3002 Human blood | US$286.1 million | 26.7% |
| 3006 Pharmaceutical goods | US$52.8 million | 4.9% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$17.5 million | 1.6% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$15.5 million | 1.4% |
| 3003 Medicaments | US$2.1 million | 0.2% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$577.0 million | 53.9% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$242.8 million | 22.7% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$38.0 million | 3.5% |
| 300610 Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents and absorbable surgical or dental haemostatics | US$31.5 million | 2.9% |
| 300220 Vaccines: for human medicine | US$26.7 million | 2.5% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$25.3 million | 2.4% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$24.0 million | 2.2% |
| 300660 Pharmaceutical goods: chemical contraceptive preparations based on hormones or spermicides | US$16.5 million | 1.5% |
| 300190 Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | US$15.4 million | 1.4% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$14.3 million | 1.3% |
Shares are of Costa Rica's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Costa Rica's trade.
More Costa Rica products
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 85 Electrical machinery and equipment and parts thereof
- 08 Fruit and nuts, edible
- 27 Mineral fuels, mineral oils and products of their distillation
- 87 Vehicles
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 39 Plastics and articles thereof
- 21 Miscellaneous edible preparations
- 72 Iron and steel
- 48 Paper and paperboard
- 20 Preparations of vegetables, fruit, nuts or other parts of plants
- 73 Iron or steel articles
Costa Rica pharmaceutical products: questions and answers
How much pharmaceutical products does Costa Rica export?
In 2024, Costa Rica exported US$237.5 million of pharmaceutical products (HS chapter 30), 0.9% of its total exports. That ranks it 63 of 213 exporting countries in the data.
What are Costa Rica's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$105.9 million), Human blood (3002, US$80.6 million), Pharmaceutical goods (3006, US$29.4 million).
How much pharmaceutical products does Costa Rica import?
In 2024, Costa Rica imported US$1.1 billion of pharmaceutical products (HS chapter 30), 4.5% of its total imports. That ranks it 64 of 226 importing countries in the data.
What are Costa Rica's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$696.8 million), Human blood (3002, US$286.1 million), Pharmaceutical goods (3006, US$52.8 million).
